Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study

Background Syndromic surveillance through web or phone-based polling has been used to track the course of infectious diseases worldwide. Our study objective was to describe the characteristics, symptoms, and self-reported testing rates of respondents in three different COVID-19 symptom surveys in Canada. Methods This was a cross-sectional study using three distinct Canada-wide web-based surveys, and phone polling in Ontario. All three sources contained self-reported information on COVID-19 symptoms and testing. In addition to describing respondent characteristics, we examined symptom frequency and the testing rate among the symptomatic, as well as rates of symptoms and testing across respondent groups. Results We found that over March- April 2020, 1.6% of respondents experienced a symptom on the day of their survey, 15% of Ontario households had a symptom in the previous week, and 44% of Canada-wide respondents had a symptom in the previous month. Across the three surveys, SARS-CoV-2-testing was reported in 2–9% of symptomatic responses. Women, younger and middle-aged adults (versus older adults) and Indigenous/First nations/Inuit/Métis were more likely to report at least one symptom, and visible minorities were more likely to report the combination of fever with cough or shortness of breath. Interpretation The low rate of testing among those reporting symptoms suggests significant opportunity to expand testing among community-dwelling residents of Canada. Syndromic surveillance data can supplement public health reports and provide much-needed context to gauge the adequacy of SARS-CoV-2 testing rates.

[1]  P. Rochon,et al.  Sex‐ and Age‐Specific Differences in COVID‐19 Testing, Cases, and Outcomes: A Population‐Wide Study in Ontario, Canada , 2020, Journal of the American Geriatrics Society.

[2]  I. Bogoch,et al.  Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada , 2020, JAMA network open.

[3]  M. Jorge Cardoso,et al.  Real-time tracking of self-reported symptoms to predict potential COVID-19 , 2020, Nature Medicine.

[4]  Carlos Del Rio,et al.  Mild or Moderate Covid-19. , 2020, The New England journal of medicine.

[5]  P. Fonda-Pascual,et al.  Chilblain‐like lesions on feet and hands during the COVID‐19 Pandemic , 2020, International journal of dermatology.

[6]  C. Hopkins,et al.  Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. , 2020, JAMA.

[7]  Li-Shan Huang,et al.  Taking Account of Asymptomatic Infections in Modeling the Transmission Potential of the COVID-19 Outbreak on the Diamond Princess Cruise Ship , 2020, medRxiv.

[8]  Georgia Salanti,et al.  The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis , 2020, medRxiv.

[9]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  M. Lipsitch,et al.  Defining the Epidemiology of Covid-19 - Studies Needed. , 2020, The New England journal of medicine.

[11]  J. Brownstein,et al.  Comparison of crowd-sourced, electronic health records based, and traditional health-care based influenza-tracking systems at multiple spatial resolutions in the United States of America , 2018, BMC Infectious Diseases.

[12]  Samarth Swarup,et al.  Combining Participatory Influenza Surveillance with Modeling and Forecasting: Three Alternative Approaches , 2017, JMIR public health and surveillance.

[13]  M. Smolinski,et al.  Participatory Disease Surveillance: Engaging Communities Directly in Reporting, Monitoring, and Responding to Health Threats , 2017, JMIR public health and surveillance.

[14]  Rumi Chunara,et al.  Determinants of Participants’ Follow-Up and Characterization of Representativeness in Flu Near You, A Participatory Disease Surveillance System , 2017, JMIR public health and surveillance.

[15]  北村 聖 "The New England Journal of Medicine". , 1962, British medical journal.